Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit	Treasury Stock
Beginning of period (in shares) at Jan. 31, 2024		124,867,000
Balance, beginning of period at Jan. 31, 2024	$ 147,174	$ 148	$ 942,622	$ (4,183)	$ (679,172)	$ (112,241)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)		322,000
Exercise of stock options	1,137		1,137
Vested restricted stock units converted to common shares, net of shares withheld for employee taxes (in shares)		2,961,000
Vested restricted stock units converted to common shares, net of shares withheld for employee taxes	(1,413)	$ 4	(1,417)
Issuance of restricted stock (in shares)		138,000
Issuance of common stock under employee stock purchase plan (in shares)		805,000
Issuance of common stock under employee stock purchase plan	3,689		3,689
Stock-based compensation	37,327		37,327
Repurchase of common stock (in shares)		(1,083,000)
Repurchase of common stock	(6,961)					(6,961)
Other comprehensive income (loss)	(318)			(318)
Net income (loss)	(20,673)				(20,673)
End of period (in shares) at Oct. 31, 2024		128,010,000
Balance, end of period at Oct. 31, 2024	159,962	$ 152	983,358	(4,501)	(699,845)	(119,202)
Beginning of period (in shares) at Jul. 31, 2024		127,145,000
Balance, beginning of period at Jul. 31, 2024	162,803	$ 150	966,550	(4,359)	(687,046)	(112,492)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)		63,000
Exercise of stock options	346		346
Vested restricted stock units converted to common shares, net of shares withheld for employee taxes (in shares)		1,550,000
Vested restricted stock units converted to common shares, net of shares withheld for employee taxes	2,373	$ 2	2,371
Issuance of common stock under employee stock purchase plan (in shares)		292,000
Issuance of common stock under employee stock purchase plan	1,338		1,338
Stock-based compensation	12,753		12,753
Repurchase of common stock (in shares)		(1,040,000)
Repurchase of common stock	(6,710)					(6,710)
Other comprehensive income (loss)	(142)			(142)
Net income (loss)	(12,799)				(12,799)
End of period (in shares) at Oct. 31, 2024		128,010,000
Balance, end of period at Oct. 31, 2024	$ 159,962	$ 152	983,358	(4,501)	(699,845)	(119,202)
Beginning of period (in shares) at Jan. 31, 2025	126,999,461	126,999,000
Balance, beginning of period at Jan. 31, 2025	$ 153,193	$ 153	996,477	(5,969)	(707,120)	(130,348)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)	279,553	279,000
Exercise of stock options	$ 1,773		1,773
Vested restricted stock units converted to common shares, net of shares withheld for employee taxes (in shares)		3,595,000
Vested restricted stock units converted to common shares, net of shares withheld for employee taxes	(18,490)	$ 4	(18,494)
Issuance of restricted stock (in shares)		67,000
Issuance of common stock under employee stock purchase plan (in shares)		605,000
Issuance of common stock under employee stock purchase plan	3,167	$ 1	3,166
Stock-based compensation	38,268		38,268
Repurchase of common stock (in shares)		(8,539,000)
Repurchase of common stock	(60,009)					(60,009)
Other comprehensive income (loss)	3,613			3,613
Net income (loss)	$ 33,657				33,657
End of period (in shares) at Oct. 31, 2025	123,005,705	123,006,000
Balance, end of period at Oct. 31, 2025	$ 155,172	$ 158	1,021,190	(2,356)	(673,463)	(190,357)
Beginning of period (in shares) at Jul. 31, 2025		123,126,000
Balance, beginning of period at Jul. 31, 2025	152,529	$ 156	1,010,599	(2,674)	(679,599)	(175,953)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)		192,000
Exercise of stock options	1,334		1,334
Vested restricted stock units converted to common shares, net of shares withheld for employee taxes (in shares)		1,138,000
Vested restricted stock units converted to common shares, net of shares withheld for employee taxes	(4,489)	$ 1	(4,490)
Issuance of common stock under employee stock purchase plan (in shares)		249,000
Issuance of common stock under employee stock purchase plan	1,303	$ 1	1,302
Stock-based compensation	12,445		12,445
Repurchase of common stock (in shares)		(1,699,000)
Repurchase of common stock	(14,404)					(14,404)
Other comprehensive income (loss)	318			318
Net income (loss)	$ 6,136				6,136
End of period (in shares) at Oct. 31, 2025	123,005,705	123,006,000
Balance, end of period at Oct. 31, 2025	$ 155,172	$ 158	$ 1,021,190	$ (2,356)	$ (673,463)	$ (190,357)